Koninklijke Philips | PHG - Current Liabilities


Koninklijke Philips reported EUR8.25B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Boston Scientific USD 5.33B 138M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Demant DKK 5.79B 301M Jun/2025
Dexcom USD 3.34B 27.3M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Fresenius EUR 9.56B 1.27B Sep/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Getinge SEK 15.05B 169M Dec/2024
Globus Medical USD 465.96M 41.29M Sep/2025
GN Store Nord DKK 7.47B 420M Sep/2025
Hitachi JPY 6.97T 788.22B Dec/2025
Hologic USD 951.3M 25.9M Dec/2025
Idexx Laboratories USD 1.25B 27.93M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 50.87B 3.31B Sep/2025
Koninklijke Philips EUR 8.25B 1.05B Sep/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Philips EUR 7.03B 171M Sep/2025
ResMed USD 1.25B 7.39M Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Steris USD 888.9M 37.7M Sep/2025
Stryker USD 7.79B 380M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Terumo JPY 296.3B 24.4B Sep/2025
Zimmer Biomet Holdings USD 2.4B 296.6M Sep/2025